T0	Disease 120 133	breast cancer
#1	AnnotatorNotes T0	DOID:1612
T1	Disease 172 178	tumors
#2	AnnotatorNotes T1	DOID:162
T2	Disease 465 470	tumor
#3	AnnotatorNotes T2	DOID:162
T3	Disease 703 709	tumors
T4	Disease 1000 1013	breast cancer
T5	Disease 1085 1090	tumor
T6	Disease 1318 1331	breast cancer
T7	Disease 1525 1531	tumors
T8	Disease 1541 1558	ovarian carcinoma
#9	AnnotatorNotes T8	DOID:4001
T9	Disease 1563 1587	hepatocellular carcinoma
#10	AnnotatorNotes T9	DOID:684
T10	Gene-Protein 93 97	ZEB1
#11	AnnotatorNotes T10	HGNC:11642
T11	Gene-Protein 205 209	ZEB1
T12	Gene-Protein 901 905	ZEB1
T13	Gene-Protein 320 324	ZEB1
T14	Gene-Protein 657 661	ZEB1
T15	Gene-Protein 935 939	ZEB1
T16	Gene-Protein 1051 1055	ZEB1
T17	Gene-Protein 1493 1497	ZEB1
T18	Gene-Protein 1396 1400	ZEB1
T19	Gene-Protein 1220 1224	ZEB1
T20	Gene-Protein 534 538	ZEB1
T21	Gene-Protein 411 415	ZEB1
T22	Gene-Protein 384 387	ATM
#12	AnnotatorNotes T22	HGNC:795
T23	Gene-Protein 806 810	ZEB1
T24	Gene-Protein 389 392	CD4
#13	AnnotatorNotes T24	HGNC:1678
T25	Gene-Protein 398 402	PIM3
#14	AnnotatorNotes T25	HGNC:19310
T26	Biomarker 190 209	high levels of ZEB1
T27	Biomarker 320 324	ZEB1
T28	Biomarker 384 387	ATM
T29	Biomarker 389 392	CD4
T30	Biomarker 398 402	PIM3
T31	Drug-Class 256 259	NAT
T32	Gene-Protein 601 605	CHK1
#15	AnnotatorNotes T32	HGNC:1925
T33	Drug-Class 153 156	NAT
T34	Drug-Class 865 868	NAT
T35	Gene-Protein 1229 1233	ZEB2
#16	AnnotatorNotes T35	HGNC:14881
T36	Biomarker 93 108	ZEB1 expression
T37	Biomarker 411 426	ZEB1 expression
R1	Association Arg1:T37 Arg2:T2	
R2	Association Arg1:T36 Arg2:T0	
T38	Biomarker 1220 1279	ZEB1 and ZEB2 mRNA expression as well as protein expression
R3	Prognostic-Poor Arg1:T38 Arg2:T6	
T39	Biomarker 1051 1055	ZEB1
T40	Biomarker 935 950	ZEB1 expression
R4	Association Arg1:T39 Arg2:T5	
R5	Prognostic-Poor Arg1:T40 Arg2:T4	
T41	Disease 1457 1461	TNBC
#7	AnnotatorNotes T41	DOID:0060081
T42	Biomarker 1396 1419	ZEB1 protein expression
R6	Prognostic-Poor Arg1:T42 Arg2:T41	
T43	Biomarker 1493 1497	ZEB1
T44	Collection 1526 1587	umors, such as ovarian carcinoma and hepatocellular carcinoma
R7	Association Arg1:T43 Arg2:T44	
T45	Drug-Class 718 735	cytotoxic therapy
T46	Biomarker 657 661	ZEB1
#4	AnnotatorNotes T27	D000071799
#8	AnnotatorNotes T28	C576324
#17	AnnotatorNotes T29	D015704
#18	AnnotatorNotes T30	C499249
T47	Biomarker 534 538	ZEB1
R9	Mediated-Non-Response Arg1:T45 Arg2:T3	
R10	Mediator Arg1:T45 Arg2:T46	
T48	Biomarker 897 923	low ZEB1 expression levels
T49	Biomarker 801 828	high ZEB1 expression levels
R11	Mediated-Non-Response Arg1:T31 Arg2:T1	
R12	Mediator Arg1:T31 Arg2:T26	
R8	Mediated-Non-Response Arg1:T34 Arg2:T3	
R13	Mediator Arg1:T34 Arg2:T49	
